PATENT CLAIM ANALYSIS

Application Number: 16277871
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "346000"]

Abstract:
The present invention relates to compositions and methods for the treatment of amyotrophic lateral sclerosis. More specifically, the present invention relates to novel combinatorial therapies for treating amyotrophic lateral sclerosis or a related disorder.

Claim (Index 1):
A method for treating a subject suffering from amyotrophic lateral sclerosis (ALS) or a related motor neuron disorder, comprising administering to said subject an effective amount of acamprosate and baclofen, or salts, or sustained-release formulations thereof.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 99.0
- Lexical Diversity: 1.37037
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14473245', '16100923', '15005222', '14473142', '15011900']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8209829075444504
- 35 USC 102 Novelty (BERT): 0.6814116534508321
- Combined Prediction Score: 0.8070257821350886
- Mean Citation Score: 635.188344
- Max Citation Score: 722.7521
- Similarity Product: 660.1726631569982

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test